Ledger.Open graph →

SEC Form D · filed December 16, 2020

Auron Therapeutics, Inc

Offering

$15.4M

Sold

$15.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WELLESLEY, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Anna D. French · Wellesley, MADirector Katharine Yen · Wellesley, MAExec · Director Alon D. Lazarus · Wellesley, MADirector Isaac Ciechanover · Wellesley, MADirector John D. Higgons · Wellesley, MADirector Hanxiong Li · Laguna Hills, CADirector Mark Dinner · Dover, DEDirector James Mackay · Laguna Hills, CADirector Ronald D. Dodson · Dallas, TXExec · Director Ricardo Bekin · Chicago, ILExec · Director Steven Glick · Brooklyn, NYDirector Matthew Glick · Brooklyn, NYDirector William Hapworth · Brooklyn, NYDirector Isaac Ciechanover · Wellesley, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗